506239 Sigma-AldrichBupropion Hydrochloride - CAS 31677-93-7 - Calbiochem
Bupropion is a non-selective inhibitor of dopamine and noradrenalin transporters. Also an antagonist for neuronal nicotinic acetylcholine receptors (nAChrs).
More>> Bupropion is a non-selective inhibitor of dopamine and noradrenalin transporters. Also an antagonist for neuronal nicotinic acetylcholine receptors (nAChrs). Less<<同義語: Dopamine and noradrenalin Transporter Inibitor, Bupropion
お勧めの製品
概要
| Replacement Information |
|---|
主要スペック表
| CAS # | Empirical Formula |
|---|---|
| 31677-93-7 | C₁₃H₁₈ClNO·HCl |
価格&在庫状況
| カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
|---|---|---|---|---|---|---|
| 5.06239.0001 |
|
ガラスビン | 50 mg |
|
— |
| References | |
|---|---|
| References | Budzynska, B. et al. 2011 Pharmacol. Rep. 63, 71. Dwoskin, P., et al. 2006. CNS Drug Rev. 12, 178. Soroko, F., et al. 1977. J. Pharm. Pharmacol. 29, 769. |
| Product Information | |
|---|---|
| CAS number | 31677-93-7 |
| Form | White solid |
| Hill Formula | C₁₃H₁₈ClNO·HCl |
| Chemical formula | C₁₃H₁₈ClNO·HCl |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | DAT/NET |
| Primary Target K<sub>i</sub> | 1.4 µ |
| Purity | ≥99% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information | |
|---|---|
| R Phrase | R: 22 Harmful if swallowed. |
| S Phrase | S: 46 If swallowed, seek medical advice immediately and show this container or label. |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| カタログ番号 | GTIN |
| 5.06239.0001 | 04055977243185 |
Documentation
Bupropion Hydrochloride - CAS 31677-93-7 - Calbiochem (M)SDS
| タイトル |
|---|
参考資料
| 参考資料の概要 |
|---|
| Budzynska, B. et al. 2011 Pharmacol. Rep. 63, 71. Dwoskin, P., et al. 2006. CNS Drug Rev. 12, 178. Soroko, F., et al. 1977. J. Pharm. Pharmacol. 29, 769. |



